INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – CAPR

Pomerantz LLP announced that a class action lawsuit has been filed against Capricor Therapeutics (NASDAQ: CAPR). The release provides no allegations, claimed damages, filing period, or operational details, but the litigation introduces a potential legal and investor-sentiment overhang for the biotech company.